Asset Details
Do you wish to reserve the book?
Burden of disease attributable to high body mass index in Belgium: a comparative risk assessment analysis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Burden of disease attributable to high body mass index in Belgium: a comparative risk assessment analysis
Do you wish to request the book?
Burden of disease attributable to high body mass index in Belgium: a comparative risk assessment analysis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Burden of disease attributable to high body mass index in Belgium: a comparative risk assessment analysis
2025
Overview
Background and methodsHigh body mass index (BMI) is a major risk factor for several non-communicable diseases. The increasing concern about the health and economic burden of BMI makes it essential for countries to track their progress on major modifiable risk exposures. The aim of the study is to estimate the burden attributable to high BMI in Belgium, in terms of years of life lost due to disability (YLD), years of life lost due to premature mortality (YLL) and disease costs, using comparative risk assessment. We followed the general framework established in the Global Burden of Diseases, Injuries and Risk Factors study. Population attributable fractions were calculated for the year 2018 for selected health outcomes using local estimates of BMI and burden of disease estimates from the Belgian Burden of Disease study.ResultsAccording to our figures, around 37 800 YLD, 56 000 YLL and €1.85 billion in healthcare costs can be attributed to a high BMI. Diabetes had the highest number of YLD attributable to high BMI followed by musculoskeletal disorders. Cardiovascular diseases accounted for the highest burden in terms of YLL attributable to high BMI, followed by diabetes and different forms of cancers (i.e., breast, colon and rectum and oesophageal cancer).ConclusionA substantial proportion of the burden of disease could be prevented when reducing BMI in Belgium. This evidence on the impact of risk factors is important for monitoring disease burdens and setting priorities for health prevention policies.
Publisher
BMJ Publishing Group Ltd,BMJ Publishing Group LTD,BMJ Publishing Group
Subject
